Prior to the coronavirus pandemic, Teladoc (NYSE:TDOC) was growing rapidly. The global health crisis accelerated that growth. However, pandemic benefits turned to a detriment for the telehealth giant, and the stock got painted with the dreaded “pandemic play” brush, prompting some unknowing...